Search bioRxiv⌕ Search

Biology subjects

Tambaro, S.

Publications and source records attributed to Tambaro, S..

2 recordsLinked to original sources

Intramembrane protease SPPL2b deficiency linked to synaptic proteostasis remodeling with brain aging

Signal peptide peptidase-like 2b (SPPL2b) is a brain-enriched intramembrane protease implicated in synaptic function, immune signaling, and neuronal development, but its physiological role in brain and neuronal homeostasis remains poorly understood. We investigated the impact of constitutive Sppl2b deletion on the brain proteome and neuronal function using quantitative shotgun proteomics in cortex and hippocampus from wild-type and SPPL2b-deficient mice at 3 and 12 months, combined with western blot, immunofluorescence, dendritic spine analysis, and behavioral testing. SPPL2b deficiency was associated with alterations in biological processes linked to axonal transport and synaptic vesicle trafficking, including consistent upregulation of the kinesin motor protein KIF1A and vesicle-associated membrane protein 2 (VAMP2). SPPL2b deletion also attenuated age-associated proteomic changes in synaptic pathways and was accompanied by increased dendritic spine density, morphological remodeling of pyramidal neurons, increased locomotor activity, and reduced anxiety-like behavior. These findings reveal a previously unrecognized association between SPPL2b and synaptic proteome remodeling during aging and nominate SPPL2b-dependent pathways as candidates for further mechanistic and functional investigation in neurodegenerative disease.

neuroscience↗

Signal Peptide Peptidase-Like 2b affects APP cleavage and exhibits a biphasic Aβ-mediated expression in Alzheimer's disease.

Alzheimers disease (AD) is a multifactorial disorder driven by abnormal amyloid {beta}-peptide (A{beta}) levels. To identify new druggable pathways involved in the A{beta} cascade we here investigated the AD pathophysiological role of the presenilin-like intramembrane protease signal peptide peptidase-like 2b (SPPL2b). A{beta}42 induced a biphasic modulation of SPPL2b expression in human cell lines and ex vivo mouse brain slices. In addition, SPPL2b was elevated in AppNL-G-F knock-in AD mice as well as in human AD samples. Early high neuronal expression of SPPL2b was followed by a downregulation in late AD pathology in both AppNL-G-F mice and Braak stage V AD brains. Importantly, SPPL2b overexpression or its genetic deletion significantly increased or reduced APP cleavage and A{beta} production, respectively. Thus, our results strongly support the involvement of SPPL2b in AD pathology. The early A{beta}-induced SPPL2b upregulation may enhance A{beta} production in a vicious cycle further aggravating the A{beta} pathology suggesting SPPL2b as a potential anti-A{beta} drug target.

neuroscience↗